Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. CARE Ratings's annualized ROCE % for the quarter that ended in Mar. 2026 was 29.43%.
ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.
Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.
CARE Ratings ROCE % Related Terms
CARE Ratings ROCE % Historical Data
* Premium members only.
The historical data trend for CARE Ratings's ROCE % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
(1) Note:
The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CARE Ratings (NSE:CARERATING) has a ROCE % of 29.43% as of Mar. 2026.
Is CARE Ratings' ROCE % too high?
CARE Ratings' current ROCE % is 29.43%. The Capital Markets industry median ROCE % is 6.15. CARE Ratings' value of 29.43% is 378.5% above this industry median. Overall, CARE Ratings has a GF Score™ of 84/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does CARE Ratings' ROCE % compare to SPGI and CME?
CARE Ratings' ROCE % of 29.43% can be compared against companies in the Capital Markets industry. The industry median ROCE % is 6.15. CARE Ratings' value of 29.43% is 378.5% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Capital Markets company?
The median ROCE % among Capital Markets companies is 6.15, based on 691 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. CARE Ratings's current ROCE % of 29.43% is 378.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Capital Markets industry, the median ROCE % is 6.15 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CARE Ratings's current ROCE % is 29.43%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CARE Ratings stock overvalued right now?
Based on GuruFocus' analysis, CARE Ratings (NSE:CARERATING) is currently considered Fairly Valued. The stock's GF Value™ is ₹1,719.38, compared to a current price of ₹1,749.20 — trading 1.7% above its estimated fair value. The current ROCE % is 29.43% and 378.5% above the Capital Markets industry median of 6.15. CARE Ratings' overall GF Score™ is 84/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For CARE Ratings (NSE:CARERATING), the current ROCE % is 29.43% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is CARE Ratings (NSE:CARERATING) Overvalued in 2026?
Based on GuruFocus' analysis, CARE Ratings stock appears to be overvalued.
The current stock price of ₹1,749.20 is trading 1.7% above its estimated GF Value™ of ₹1,719.38.
GuruFocus considers CARE Ratings to be Fairly Valued.
Key valuation signals for NSE:CARERATING:
ROCE %: 29.43%
GF Value™: ₹1,719.38 vs. price of ₹1,749.20 (1.7% above fair value)
Industry Position: 378.5% above the Capital Markets median
No single metric tells the full story. See the NSE:CARERATING stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
CARE Ratings Ltd provides various credit ratings that helps corporates to raise capital for their various requirements and assists the investors to form an informed investment decision based on the credit risk and their own risk-return expectations. The company works in Bank Loan Ratings; Capital Market Instruments, Including NCDs/ Bonds/ Hybrids/ CPs/CDs, etc; Structured Finance Ratings; Monitoring Agency Services for Equity Capital; Rating of REITs /InvITs; Resolution Plan Ratings; Recovery Ratings; Issuer Ratings. The company's segment includes Ratings and related services; and Others. The company generates majority of revenue from Ratings and related services. The company has presence in India, and Outside India. It generates majority of revenue from India.
84GF Score
Get the complete analysis for NSE:CARERATING
ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:CARERATING has been successfully added to your 
